Researchers have found that ether lipids are present in significantly higher concentrations in breastmilk compared to formula and other animal- and plant-based milks.
Researchers have revealed the key biological indicators that predict when a person will have a severe reaction to COVID-19.
Researchers have uncovered 103 new unsaturated fatty acids in human-derived samples, doubling the number previously reported in human blood plasma.
Researchers have successfully developed a strip-type urine sensor that can amplify the light signal of metabolites in urine for diagnosing cancer in the field.
Researchers have developed a new device that can detect and analyse cancer cells from blood samples, enabling doctors to avoid invasive biopsy surgeries.
Scientists have designed a new way to deliver a bacterial compound known as butyrate, which has shown promise against allergic reactions in lab tests.
Severe asthmatics have a distinct biochemical (metabolite) profile detectable in their urine — a breakthrough that could lead to more effective treatments.
Scientists have identified two biological markers to improve embryo selection for IVF patients, which should help them to get pregnant sooner.
The new technology provides doctors with a non-invasive test that gives them immediate clues as to how well the course of therapy is going.
Researchers have used a urine test to identify and verify a patient's type of asthma, laying the foundation for a more personalised diagnosis and improved treatment.
Bruker's B.I.QUANT-UR 1.1 module automatically quantifies up to 150 endogenous and disease-related metabolites from urine, allowing users to obtain precise, sensitive and fully reproducible results, even below the limit of detection (LOD).
PhenoMeNal is an online portal that allows researchers and clinicians to analyse large metabolomics datasets.
A newly developed medical device pairs a handheld sensor with a smartphone app and measures the levels of various metabolites in fluid samples from patients.
Life sciences company Thermo Fisher Scientific and research centre SRI International have announced a collaboration to enhance small molecule research.
Bruker has announced a product for the quantification of metabolites in urine using nuclear magnetic resonance (NMR). The B.I.QUANT-UR module of the company's Avance IVDr (In Vitro Diagnostics research) NMR platform is designed to provide precise, sensitive and fully reproducible results that have demonstrated potential in preclinical animal and clinical/translational research.